Yamayoshi, A.; Oyama, S.; Kishimoto, Y.; Konishi, R.; Yamamoto, T.; Kobori, A.; Harada, H.; Ashihara, E.; Sugiyama, H.; Murakami, A.
Development of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA. Pharmaceutics 2020, 12, 545.
https://doi.org/10.3390/pharmaceutics12060545
AMA Style
Yamayoshi A, Oyama S, Kishimoto Y, Konishi R, Yamamoto T, Kobori A, Harada H, Ashihara E, Sugiyama H, Murakami A.
Development of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA. Pharmaceutics. 2020; 12(6):545.
https://doi.org/10.3390/pharmaceutics12060545
Chicago/Turabian Style
Yamayoshi, Asako, Shota Oyama, Yusuke Kishimoto, Ryo Konishi, Tsuyoshi Yamamoto, Akio Kobori, Hiroshi Harada, Eishi Ashihara, Hiroshi Sugiyama, and Akira Murakami.
2020. "Development of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA" Pharmaceutics 12, no. 6: 545.
https://doi.org/10.3390/pharmaceutics12060545
APA Style
Yamayoshi, A., Oyama, S., Kishimoto, Y., Konishi, R., Yamamoto, T., Kobori, A., Harada, H., Ashihara, E., Sugiyama, H., & Murakami, A.
(2020). Development of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA. Pharmaceutics, 12(6), 545.
https://doi.org/10.3390/pharmaceutics12060545